p38-alpha kinase inhibitor (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namep38-alpha kinase inhibitor (Pfizer)
Drug Alias Namep38-alpha kinase inhibitor (Pfizer)SC-409PHA-00797804
ClassificationSmall molecules
Mechanisms of ActionPhotoprotectantP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsInflammationHypertension, Pulmonary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsInflammationHypertension, Pulmonary

Other Information

ATC CodeN/A
Related LinksN/A